• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

biosimilars

Makary
Favicon Fierce Pharma

FDA's Makary shares policy requests with Congress

FDA Commissioner Marty Makary, M.D., has laid out an extensive legislative wish list in his fiscal year 2027 budget proposal to Congress.
Angus Liu , Eric Sagonowsky , Zoey Becker Apr 7, 2026 11:04am
graphic of a larger shark chomping up a smaller one

Coherus scratches the Surface with $65M buy

Jun 16, 2023 10:45am
drug delivery

Fresenius Kabi nabs smart infusion pump maker Ivenix for $240M

Mar 31, 2022 12:36pm
hong kong

Henlius falls short of IPO goal but still rakes in $410M on HKEX

Sep 18, 2019 10:40am
Patrick Soon-Shiong

Sorrento sues Soon-Shiong over cancer drug 'catch-and-kill'

Apr 3, 2019 6:37pm
Innovent building

Innovent buys Chinese rights to Incyte drugs for $40M upfront

Dec 17, 2018 9:23am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings